Staff Publications: July 2017

  1. Adams DL, Adams DK, He J, et al. Sequential Tracking of Pd-L1 Expression and Rad50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing Radiotherapy. Clin Cancer Res. 2017. PMID: 28679765.
  2. Anthony S, Peterson JR, Ji Y. Use of Inosine Monophosphate Dehydrogenase Activity Assay to Determine the Specificity of Parp-1 Inhibitors. Methods Mol Biol. 2017;1608:337-342. PMID: 28695520.
  3. Arthur DW, Winter KA, Kuerer HM, et al. Nrg Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report from a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for in-Breast Recurrence. Int J Radiat Oncol Biol Phys. 2017;98(5):1028-1035. PMID: 28721885.
  4. Barta SK, Jain R, Mazumder A, et al. Pharmacokinetics-Directed Intravenous Busulfan Combined with High-Dose Melphalan and Bortezomib as a Conditioning Regimen for Patients with Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28684379.
  5. Bartel MJ, Srivastava A, Gordon S, Rothstein RI, Pohl H. Subsquamous Intestinal Metaplasia Is Common in Treatment-Naive Barrett’s Esophagus. Gastrointest Endosc. 2017. PMID: 28687439.
  6. Bazzoli A, Vance DJ, Rudolph MJ, et al. Using Homology Modeling to Interrogate Binding Affinity in Neutralization of Ricin Toxin by a Family of Single Domain Antibodies. Proteins. 2017. PMID: 28718923.
  7. Berger MJ, Ettinger DS, Aston J, et al. Nccn Guidelines Insights: Antiemesis, Version 2.2017. J Natl Compr Canc Netw. 2017;15(7):883-893. PMID: 28687576.
  8. Brennan MS, Barlotta RM, Simhan J. Frailty Assessments in Surgical Practice: What Is Frailty and How Can It Be Used in Prosthetic Health? Sexual Medicine Reviews. 2017.
  9. Brigle K, Rogers B. Pathobiology and Diagnosis of Multiple Myeloma. Seminars in Oncology Nursing. 2017.
  10. Bryan MS, Argos M, Andrulis IL, et al. Limited Influence of Germline Genetic Variation on All-Cause Mortality in Women with Early Onset Breast Cancer: Evidence from Gene-Based Tests, Single-Marker Regression, and Whole-Genome Prediction. Breast Cancer Research and Treatment. 2017;164(3):707-717.
    Burtness B, Powell M, Catalano P, et al. Randomized Phase Ii Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study. Am J Clin Oncol. 2016;39(4):340-345. PMID: 24685886. PMC4177955. NIHMS572099.
  11. Cahn DB, Handorf EA, Ghiraldi EM, et al. Contemporary Use Trends and Survival Outcomes in Patients Undergoing Radical Cystectomy or Bladder-Preservation Therapy for Muscle-Invasive Bladder Cancer. Cancer. 2017. PMID: 28743162.
  12. Chernoff J, Radu M. Recent Advances in Methods to Assess the Activity of the Kinome. F1000Res. 2017;6.
  13. Cheung M, Testa JR. Bap1, a Tumor Suppressor Gene Driving Malignant Mesothelioma. Transl Lung Cancer Res. 2017;6(3):270-278. PMID: 28713672. PMC5504107.
  14. Chwistek M. Recent Advances in Understanding and Managing Cancer Pain. F1000Res. 2017;6:945. PMID: 28690839. PMC5482325.
  15. Cobb SC. Application Strategies and Tips for Using the Nursing Professional Development Practice Model. J Nurses Prof Dev. 2017;33(4):213-216. PMID: 28683039.
  16. Correa AF, Hrebinko RL, Smaldone MC. Management of Recurrent Venous Tumor Thrombus Following Inferior Vena Cava Thrombectomy: Is Surgery the Right Answer? Eur Urol Focus. 2016;2(6):631-632. PMID: 28723496. Editorial.
  17. Dasgupta Y, Koptyra M, Hoser G, et al. Normal Abl1 Is a Tumor Suppressor and Therapeutic Target in Human and Mouse Leukemias Expressing Oncogenic Abl1 Kinases. Blood. 2016;127(17):2131-2143. PMID: 26864341. PMC4850868.
  18. Deng N, Hoyte A, Mansour YE, et al. Allosteric Hiv-1 Integrase Inhibitors Promote Aberrant Protein Multimerization by Directly Mediating Inter-Subunit Interactions: Structural and Thermodynamic Modeling Studies. Protein Sci. 2016;25(11):1911-1917. PMID: 27503276. PMC5079246.
  19. Dong Y, Ridge JA, Li T, et al. Long-Term Toxicities in 10-Year Survivors of Radiation Treatment for Head and Neck Cancer. Oral Oncol. 2017;71:122-128. PMID: 28688679.
  20. Ebersole B, Soni RS, Moran K, Lango M, Devarajan K, Jamal N. The Role of Occupational Voice Demand and Patient-Rated Impairment in Predicting Voice Therapy Adherence. J Voice. 2017. PMID: 28709763.
  21. Edelman MJ, Wang X, Hodgson L, et al. Phase Iii Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer with Cyclooxygenase-2 Overexpression: Calgb 30801 (Alliance). Journal of Clinical Oncology. 2017;35(19):2184-2192. PMID:
  22. Egleston BL, Uzzo RG, Wong YN. Latent Class Survival Models Linked by Principal Stratification to Investigate Heterogenous Survival Subgroups among Individuals with Early-Stage Kidney Cancer. Journal of the American Statistical Association. 2017;112(518):534-546. PMID:
  23. El-Deiry WS, Taylor B, Neal JW. Tumor Evolution, Heterogeneity, and Therapy for Our Patients with Advanced Cancer: How Far Have We Come? Am Soc Clin Oncol Educ Book. 2017;37:e8-e15. PMID: 28746017.
  24. Epperla N, Maddocks KJ, Salhab M, et al. C-Myc-Positive Relapsed and Refractory, Diffuse Large B-Cell Lymphoma: Impact of Additional “Hits” and Outcomes with Subsequent Therapy. Cancer. 2017. PMID: 28749548.
  25. Ghatalia P, Nagarathinam R, Cooper H, Geynisman DM, El-Deiry WS. Mismatch Repair Deficient Metastatic Colon Cancer and Urothelial Cancer: A Case Report of Sequential Immune Checkpoint Therapy. Cancer Biol Ther. 2017:0. PMID: 28726535.
  26. Gilbert EA, Krafty RT, Bleicher RJ, Egleston BL. On the Use of Summary Comorbidity Measures for Prognosis and Survival Treatment Effect Estimation. Health Services and Outcomes Research Methodology. 2017:1-19.
  27. Gore JL, du Plessis M, Santiago-Jimenez M, et al. Decipher Test Impacts Decision Making among Patients Considering Adjuvant and Salvage Treatment after Radical Prostatectomy: Interim Results from the Multicenter Prospective Pro-Impact Study. Cancer. 2017;123(15):2850-2859.
  28. Gutierrez Diez PJ, Su Y, Russo J. Immunocytochemical Stem Cell Markers Can Predict Clinical Stage of Breast Cancer. Oncol Rep. 2017. PMID: 28714035.
  29. Haifler M, Kutikov A. Harnessing Proteinuria as a Predictor of Postsurgical Outcomes in Kidney Cancer Patients. Eur Urol Focus. 2016;2(6):623-624. PMID: 28723494.
  30. Hammers HJ, Plimack ER, Infante JR, et al. Safety and Efficacy of Nivolumab in Combination with Ipilimumab in Metastatic Renal Cell Carcinoma: The Checkmate 016 Study. J Clin Oncol. 2017:Jco2016721985. PMID: 28678668.
  31. Harper MG, Maloney P, Cobb SC. Application Strategies and Tips for Using the Nursing Professional Development Practice Model. J Nurses Prof Dev. 2017;33(4):213-216.
  32. Heinrich MC, Rankin C, Blanke CD, et al. Correlation of Long-Term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors with Next-Generation Sequencing Results Analysis of Phase 3 Swog Intergroup Trial S0033. JAMA Oncol. 2017;3(7):944-952.
  33. Henry KA, Swiecki-Sikora AL, Stroup AM, Warner EL, Kepka D. Area-Based Socioeconomic Factors and Human Papillomavirus (Hpv) Vaccination among Teen Boys in the United States. BMC Public Health. 2017;18(1):19. PMID: 28709420. PMC5513319.
  34. Hernandez-Borrero LJ, Zhang S, Lulla A, Dicker DT, El-Deiry WS. Cb002, a Novel P53 Tumor Suppressor Pathway-Restoring Small Molecule Induces Tumor Cell Death through the Pro-Apoptotic Protein Noxa. Cell Cycle. 2017:0. PMID: 28749203.
  35. Hooper R, Zaidi MR, Soboloff J. The Heterogeneity of Store-Operated Calcium Entry in Melanoma. Sci China Life Sci. 2016;59(8):764-769. PMID: 27417567. PMC4991353. NIHMS810145.
  36. Huang F, Goyal N, Sullivan K, et al. Targeting Brca1- and Brca2-Deficient Cells with Rad52 Small Molecule Inhibitors. Nucleic Acids Res. 2016;44(9):4189-4199. PMID: 26873923. PMC4872086.
  37. Hussaini A, Olszanski AJ, Stein CA, Bosch B, Nemeth P. Impact of an Alternative Steroid on the Relative Bioavailability and Bioequivalence of a Novel Versus the Originator Formulation of Abiraterone Acetate. Cancer Chemother Pharmacol. 2017. PMID: 28695267.
  38. Infante JR, Cohen RB, Kim KB, et al. Erratum To: A Phase I Dose-Escalation Study of Selumetinib in Combination with Erlotinib or Temsirolimus in Patients with Advanced Solid Tumors. Invest New Drugs. 2017. PMID: 28676972.
  39. Ishii S, Ishii S, Suzuki S, et al. Population Dynamics of Electrogenic Microbial Communities in Microbial Fuel Cells Started with Three Different Inoculum Sources. Bioelectrochemistry. 2017;117:74-82. PMID:
  40. Jackson-Rose J, Del Monte J, Groman A, et al. Chemotherapy Extravasation: Establishing a National Benchmark for Incidence among Cancer Centers. Clin J Oncol Nurs. 2017;21(4):438-445. PMID: 28738039.
  41. Jamal N. Reflections on Patient-Centered Care: From the Perspective of a Young Otolaryngologist. Otolaryngol Head Neck Surg. 2017:194599817721455. PMID: 28719758.
  42. Ji Y. Approaches for Investigating Translational Regulation Controlled by Parp1: Biotin-Based Uv Cross-Linking and Luciferase Reporter Assay. Methods Mol Biol. 2017;1608:201-210. PMID: 28695512.
  43. Jiang P, Li Y, Poleshko A, et al. The Protein Encoded by the Ccdc170 Breast Cancer Gene Functions to Organize the Golgi-Microtubule Network. EBioMedicine. 2017. PMID: 28687497.
  44. Joshi S, Kutikov A. Understanding Mutational Drivers of Risk: An Important Step toward Personalized Care for Patients with Renal Cell Carcinoma. Eur Urol Focus. 2016. PMID: 28753782.
  45. Kang B, Yang W, Lee S, et al. Precisely Tuneable Energy Transfer System Using Peptoid Helix-Based Molecular Scaffold. Sci Rep. 2017;7(1):4786. PMID: 28684782. PMC5500559.
  46. Kotova E, Tulin AV. High-Throughput Colorimetric Assay for Identifying Parp-1 Inhibitors Using a Large Small-Molecule Collection. Methods Mol Biol. 2017;1608:299-312. PMID: 28695517.
  47. Kutikov A. Surveillance of Small Renal Masses in Young Patients: A Viable Option in the Appropriate Candidate. Eur Urol Focus. 2016;2(6):567-568. PMID: 28723482.
  48. Lee Z, Waldorf BT, Cho EY, Liu JC, Metro MJ, Eun DD. Robotic Ureteroplasty with Buccal Mucosa Graft for the Management of Complex Ureteral Strictures. J Urol. 2017. PMID: 28736319.
  49. Li PD, Liu Z, Cheng TT, et al. Redox-Dependent Modulation of Metformin Contributes to Enhanced Sensitivity of Esophageal Squamous Cell Carcinoma to Cisplatin. Oncotarget. 2017. PMID: 28723636.
  50. Liu X, Li YS, Shinton SA, et al. Zebrafish B Cell Development without a Pre-B Cell Stage, Revealed by Cd79 Fluorescence Reporter Transgenes. J Immunol. 2017. PMID: 28739882.
  51. MacFarlane AWI, Jillab M, Smith MR, et al. Nk Cell Dysfunction in Chronic Lymphocytic Leukemia Is Associated with Loss of the Mature Cells Expressing Inhibitory Killer Cell Ig-Like Receptors. OncoImmunology. 2017.
  52. Makhov P, Naito S, Kolenko VM. Testing Parp Inhibitors Using a Murine Xenograft Model. Methods Mol Biol. 2017;1608:313-320. PMID: 28695518.
  53. Milora KA, Uppalapati SR, Sanmiguel JC, Zou W, Jensen LE. Interleukin-36beta Provides Protection against Hsv-1 Infection, but Does Not Modulate Initiation of Adaptive Immune Responses. Sci Rep. 2017;7(1):5799. PMID: 28724920. PMC5517484.
  54. Modi V, Xu Q, Adhikari S, Dunbrack RL, Jr. Assessment of Template-Based Modeling of Protein Structure in Casp11. Proteins. 2016;84 Suppl 1:200-220. PMID: 27081927. PMC5030193. NIHMS778467.
  55. Mortazavi SAR, Mortazavi G, Mortazavi SMJ. Comments on “Radiofrequency Electromagnetic Fields and Some Cancers of Unknown Etiology: An Ecological Study”. Sci Total Environ. 2017;609:1. PMID: 28732291.
  56. Mortazavi SAR, Mortazavi G, Mortazavi SMJ. Use of Cell Phones and Brain Tumors: A True Association? Neurol Sci. 2017. PMID: 28689225.
  57. Mortazavi SMJ, Mortazavi G, Paknahad M. Comment on Giuseppe Genchi Et Al. Mercury Exposure and Heart Diseases. Int. J. Environ. Res. Public Health 2017, 14, 74. Int J Environ Res Public Health. 2017;14(7). PMID: 28684671.
  58. Muffly L, Pasquini MC, Martens M, et al. Increasing Use of Allogeneic Hematopoietic Cell Transplantation in Patients Age 70 Years and Older in the United States. Blood. 2017. PMID: 28674027.
  59. Mukherjee K, Sha X, Magimaidas A, et al. Gadd45a Deficiency Accelerates Bcr-Abl Driven Chronic Myelogenous Leukemia. Oncotarget. 2017;8(7):10809-10821. PMID: 28086219. PMC5355225.
  60. O’Donnell MR, Tallman MS, Abboud CN, et al. Acute Myeloid Leukemia, Version 3.2017: Clinical Practice Guidelines in Oncology. JNCCN Journal of the National Comprehensive Cancer Network. 2017;15(7):926-957.
  61. Parsaei H, Faraz M, Mortazavi SMJ. A Multilayer Perceptron Neural Network-Based Model for Predicting Subjective Health Symptoms in People Living in the Vicinity of Mobile Phone Base Stations. Ecopsychology. 2017;9(2):99-105.
  62. Pazina T, James AM, MacFarlane AWI, et al. The Anti-Slamf7 Antibody Elotuzumab Mediates Nk Cell Activation through Both Cd16-Dependent and –Independent Mechanisms. OncoImmunology. 2017.
  63. Perez-Leal O, Barrero CA, Merali S. Pharmacological Stimulation of Nuclear Factor (Erythroid-Derived 2)-Like 2 Translation Activates Antioxidant Responses. J Biol Chem. 2017. PMID: 28684421.
  64. Pollack A, Kwon D, Walker G, et al. Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated with Radiotherapy for Prostate Cancer. J Natl Cancer Inst. 2017;109(2):1-8. PMID: 28376214.
  65. Radu M, Chernoff J. Recent Advances in Methods to Assess the Activity of the Kinome. F1000Res. 2017;6:1004. PMID: 28713564. PMC5490475.
  66. Ramamurthy C, Doyle J, Uzzo RG, Kutikov A, Smaldone MC, Geynisman DM. Role of Collaboration between Urologists and Medical Oncologists in the Advanced Prostate Cancer Space. Urol Oncol. 2017. PMID: 28720409. Editorial.
  67. Richardson C, Zhang S, Hernandez Borrero LJ, El-Deiry WS. Small-Molecule Cb002 Restores P53 Pathway Signaling and Represses Colorectal Cancer Cell Growth. Cell Cycle. 2017:0. PMID: 28749206.
  68. Ristau BT, Kutikov A, Uzzo RG, Smaldone MC. Active Surveillance for Small Renal Masses: When Less Is More. Eur Urol Focus. 2016;2(6):660-668. PMID: 28723504.
  69. Ristau BT, Manola J, Haas NB, et al. Retroperitoneal Lymphadenectomy in High-Risk Non-Metastatic Renal Cell Carcinoma: An Analysis of the Assure (Ecog-Acrin 2805) Adjuvant Trial. J Urol. 2017. PMID: 28728992.
  70. Shastri A, Budhathoki A, Barta SK, et al. Stimulation of Adrenergic Activity by Desipramine Enhances Hematopoietic Stem and Progenitor Cell Mobilization Along with G-Csf in Multiple Myeloma: A Pilot Study. Am J Hematol. 2017. PMID: 28675459.
  71. Stepanova DS, Semenova G, Kuo YM, et al. An Essential Role for the Tumor Suppressor Merlin in Regulating Fatty Acid Synthesis. Cancer Res. 2017. PMID: 28729415.
  72. Sznol M, Postow MA, Davies MJ, et al. Endocrine-Related Adverse Events Associated with Immune Checkpoint Blockade and Expert Insights on Their Management. Cancer Treat Rev. 2017;58:70-76. PMID: 28689073.
  73. Thomas C, Kotova E, Tulin AV. Parp-1 Interaction with and Activation by Histones and Nucleosomes. Methods Mol Biol. 2017;1608:255-267. PMID: 28695515.
  74. Van Cleave JH, Egleston BL, Brosch S, et al. Policy Research Challenges in Comparing Care Models for Dual-Eligible Beneficiaries. Policy Polit Nurs Pract. 2017:1527154417721909. PMID: 28735567.
  75. Wang LS, Handorf EA, Ridge JA, et al. Lymph-Node-Positive Cutaneous Nonmelanoma Skin Cancer: A Poor-Prognosis Disease in Need of Treatment Intensification. Ear, Nose and Throat Journal. 2017;96(7).
  76. Wei S, Al-Saleem T. The Pathology and Molecular Genetics of Sarcomatoid Renal Cell Carcinoma: A Mini-Review. J Kidney Cancer VHL. 2017;4(2):19-23. PMID: 28725540. PMC5515895.
  77. Williams NL, Dan T, Zaorsky NG, Garg S, Den RB. The Role of Genomic Techniques in Predicting Response to Radiation Therapy. ONCOLOGY (United States). 2017;31(7):1-11.
  78. Winckworth-Prejsnar K, Lentz LK, Nardi EA, Pruthi S, Fitzgerald CL, Carlson RW. Value Tools for Patients in Cancer Care. J Natl Compr Canc Netw. 2017;15(7):872-877. PMID: 28687575.
  79. Winkels RM, Sturgeon KM, Kallan MJ, et al. The Women in Steady Exercise Research (Wiser) Survivor Trial: The Innovative Transdisciplinary Design of a Randomized Controlled Trial of Exercise and Weight-Loss Interventions among Breast Cancer Survivors with Lymphedema. Contemp Clin Trials. 2017;61:63-72. PMID: 28739540.
  80. Yadav RK, Jablonowski CM, Fernandez AG, et al. Histone H3g34r Mutation Causes Replication Stress, Homologous Recombination Defects and Genomic Instability in S. Pombe. Elife. 2017;6. PMID: 28718400. PMC5515577.
  81. Yoo E, Cheng HA, Nardacci LE, et al. Activatable Interpolymer Complex-Superparamagnetic Iron Oxide Nanoparticles as Magnetic Resonance Contrast Agents Sensitive to Oxidative Stress. Colloids Surf B Biointerfaces. 2017;158:578-588. PMID: 28750340.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s